Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Telebras (TBH) & Brazil -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (1394)	4/1/1998 11:10:00 PM
From: Eugene Goodman	Read Replies (2) \| Respond to of 22640

TBR is a Merrill Lynch Focus 1 stock. Opinion D-!-!-7 Price Objective 170 as of 12/4/97 Gene

To: Steve Fancy who wrote (1394)	4/2/1998 9:35:00 AM
From: md1derful	Read Replies (1) \| Respond to of 22640

SF: Still holding the leap position..I actually violated one of my rules to take profits when a double occurs (the leap traded higher than 36)..but I actually feel that leaps can still be purchased even at this price and I am waiting for the right price!!! In terms of biotech...I think health stocks will be under prolonged pressure as long as medicare and managed care continue to reduce payments to providers and drug companies and the biotech winners will be few and far between (jmho). Good luck with agouron...probably a winner!!